The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Moshetova L.K.

Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch №1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001

Iarovaia G.A.

Kafedra oftal'mologii i kafedra biokhimii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Minzdravsotsrazvitiia Rossii, Moskva

Tsikhonchuk T.V.

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993

Neshkova E.A.

Kafedra oftal'mologii i kafedra biokhimii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Minzdravsotsrazvitiia Rossii, Moskva

Turkina K.I.

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993

Changes in hemostasis-related parameters of blood and lacrimal fluid in patients with retinal vein occlusion

Authors:

Moshetova L.K., Iarovaia G.A., Tsikhonchuk T.V., Neshkova E.A., Turkina K.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2016;132(4): 88‑93

DOI: 10.17116/oftalma2016132488-93

Views: 1254

Downloaded: 33

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Moshetova LK, Iarovaia GA, Tsikhonchuk TV, Neshkova EA, Turkina KI. Changes in hemostasis-related parameters of blood and lacrimal fluid in patients with retinal vein occlusion. Russian Annals of Ophthalmology. 2016;132(4):88‑93. (In Russ.)
https://doi.org/10.17116/oftalma2016132488-93

Подписка 2025 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Close metadata

High prevalence of retinal vein occlusion in young people as well as treatment complexity and inadequate control of hemostatic parameters of blood and lacrimal fluid determine the significance of relevant research in patients with retinal vascular pathology. The data thus obtained may be useful for disease prognosis, severity evaluation and therapy control. This review is aimed to study hemostasis-related parameters of blood and lacrimal fluid in such patients.

Keywords:

retinal vein occlusion
hemostasis
blood
lacrimal fluid

Authors:

Moshetova L.K.

Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch №1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001

Iarovaia G.A.

Kafedra oftal'mologii i kafedra biokhimii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Minzdravsotsrazvitiia Rossii, Moskva

Tsikhonchuk T.V.

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993

Neshkova E.A.

Kafedra oftal'mologii i kafedra biokhimii GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia" Minzdravsotsrazvitiia Rossii, Moskva

Turkina K.I.

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 125993

List of references:

  1. Tul'tseva S, Astakhov Yu. Okklyuzii ven setchatki (etiologiya, patogenez, klinika, diagnostika, lechenie). SPb.: Izdatel'stvo N-L; 2010. (In Russ.)
  2. Astakhov Yu, Petrishchev N, Tul'tseva S. Tromboz ven setchatki (etiologiya, patogenez, klinika, lechenie): posobie dlya vrachey-internov i klinicheskikh ordinatorov. SPb.: SPbGMU; 2005. (In Russ.)
  3. Moshetova L, Yatsenko O, Mizgireva A, Yarovaya G, Neshkova E, Borisenko I. Application fraxiparin in the treatment of acute obstruction of the central retinal artery and ischemic neuropathy. Rossiyskie meditsinskie vesti. 2004;IX(3):50-56. (In Russ.)
  4. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia and Australia. Ophthalmology. 2010;117(2):313-319.  doi:10.1016/j.ophtha.2009.07.017
  5. Bertelsen M, Linneberg A, Christoffersen N, Vorum H, Gade E, Larsen M. Mortality in patients with central retinal vein occlusion. Ophthalmology. 2014;121(3):637-642.  doi:10.1016/j.ophtha.2013.07.025
  6. Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BE, Wong TY, Mitchell P. Retinal vein occlusion and vascular mortality. Ophthalmology. 2007;114(3):520-524.  doi:10.1016/j.ophtha.2006.06.061
  7. Hayreh SS. Central Retinal Vein Occlusion. Ocular Vascular Occlusive Disorders. 2015;621-743.  doi:10.1007/978-3-319-12781-1_24
  8. Sloop G, Holsworth RE Jr, Weidman JJ, St Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther Adv Cardiovasc Dis. 2015;9(1):19-25.  doi:10.1177/1753944714553226
  9. Sofi F, Mannini L, Marcucci R, Bolli P, Sodi A, Giambene B, Menchini U, Gensini GF, Abbate R, Prisco D. Role of haemorheological factors in patients with retinal vein occlusion. Thrombosis and Haemostasis. 2007;98(6):1215-1219. doi:10.1160/TH07-04-0247
  10. Shestakova M. Еndothelial dysfunction - a cause or a consequence of metabolic syndrome? Rossiyskiy med. zhurnal. 2001;9(2):88-101. (In Russ.)
  11. Hofman P, van Blijswijk BC, Gaillard PJ,Gaillard PJ, Vrensen GF, Schlingemann RO. Endothelial cell hypertrophy induced by vascular endothelial growth in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol. 2001;119(6):861-866.  doi:10.1001/archopht.119.6.861
  12. Pervushin Yu, Rogova S, Kovalevich N. Laboratornye metody issledovaniya sistemy gemostaza i diagnostika narushenii sistemy gemokoagulyatsii. Uchebnoe posobie. Stavropol'-Moscow: Izdatel'stvo Moskva; 2009:7-32. (In Russ.)
  13. Yarovaya G, Blokhina T, Neshkova E. Contact proteolytic activation systems of blood plasma. New concepts on the mechanisms of activation and bioregulatory functions. Laboratornaya meditsina. 2008;9:19-26. (In Russ.)
  14. Colman RW. Are hemostasis and thrombosis two sides of the same coin? Journal of Experimental Medicine. 2006;203(3):493-495.  doi:10.1084/jem.20060217
  15. Neroev V, Chesnokova N, Tankovskiy V, Pavlenko T, Grigor'ev A, Urakova N. Changes of the levels of fibrinolytic system components in the blood and tears of patients during the treatment of inflammatory retinal vein occlusions. Rossiyskiy oftal'mologicheskiy zhurnal. 2014;7(3):27-30. (In Russ.)
  16. Astakhov Yu, Petrishchev N, Varganova T, Tul'tseva S. Thrombophilia in the pathogenesis of retinal vein thrombosis. Vestnik оftal'mologii. 2008;124(3):56-58. (In Russ.)
  17. Tul'tseva S. Plasmocoagulation thrombophylia and its role in retinal vein occlusion development. Sovremennaya optometriya. 2012;1(51):27-32. (In Russ.)
  18. Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol. 2010;45(2):171-175.  doi:10.3129/i09-273
  19. Kuhli C, Scharrer I, Koch F, Ohrloff C, Hattenbach LO. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol. 2004;137(3):459-464.  doi:10.1016/j.ajo.2003.10.024
  20. Tul'tseva S. The significance of platelet glycoprotein receptor gene polymorphisms in the pathogenesis of retinal vein thrombosis. Oftal'mologicheskie vedomosti. 2008;1(4):5-12. (In Russ.)
  21. Faude F, Faude S, Siegemund A, Wiedemann P. Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group. Klin Monbl Augenheilkd. 2004;221(10):862-866.  doi:10.1055/s-2004-813610 
  22. Mamaev A. Koagulopatii: rukovodstvo. M.: Geotar-Media; 2012. (In Russ.)
  23. Mikhailova M, Sizova M, Shelankova A. Pathogenesis of retinal vein occlusions. Vestnik oftal'mologii. 2014;2:88-92. (In Russ.)
  24. Petrishchev N, Vasina L, Vlasov T, Gavrisheva N, Menshutina M. Typical forms endothelial dysfunction. Kliniko-laboratornyi konsilium. 2007;18:31-35. (In Russ.)
  25. Disfunktsiya endoteliya. Prichiny, mekhanizmy, farmakologicheskaya korrektsiya. Pod red. Petrishcheva. Spb.: Izd-vo SPbGMU; 2003. (In Russ.)
  26. Tankovskii V. Trombozy ven setchatki. M.: Voenizdat; 2000. (In Russ.)
  27. Tul'tseva S. The role of hypofibrinolysis in the development of retinal vein thrombosis. Regional'noe krovoobrashchenie i mikrotsirkulyatsiya. 2009;30(2):4-10. (In Russ.)
  28. Moshetova L, Yatsenko O, Mizgireva A, Borisenko I. Modern pharmacotherapy of acute vascular obstruction of retina and optic nerve. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2004;5:170-171. (In Russ.)
  29. Shitikova A. Trombotsitarnyi gemostaz. SPb.: GMU; 2000. (In Russ.)
  30. Shitikova A. Trombotsitopatii, vrozhdennye i priobretennye. SPb.: IITs VMA; 2008. (In Russ.)
  31. Shiffman F. Patofiziologiya krovi. Per. s angl. SPb.: BINOM; Nevskii dialekt; 2000. (In Russ.)
  32. Weisel JW. Fibrinogen and fibrin. Advances in Protein Chemistry. 2005;70:247-299.  doi:10.1016/s0065-3233(05)70008-5 
  33. Engelmann B, Luther T, Muller I. Intravascular tissue factor pathway- a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost. 2003;89(1):3-8.
  34. Pal'tsev M, Ivanov A, Severin S. Mezhkletochnye vzaimodeistviya. M.: Meditsina; 2003. (In Russ.)
  35. Yarovaya G, Neshkova E, Blokhina T, Kochergin S, Vorob'eva I, Gigineishvili D. Kallikrein-kinin system as a target for diabetic retinopathy treatment. Vestnik оftal'mologii. 2012;128(4):78-81. (In Russ.)
  36. Al'fonsov V, Al'fonsova N. Rol' sosudistoi stenki v mekhanizmakh tromboza pri atsidoze. V kn.: Aterotromboz - probl. sovrem.: Tezisy dokladov. Moscow; 2001:62-63. (In Russ.)
  37. Shelkovnikova T, Vavin V, Katsadze Yu. The system of hemostasis in patients with retinal vascular pathology. Kubanskii nauch. med. vestnik. 2013;2:62-65. (In Russ.)
  38. Williamson T, Rumly A, Lowe G. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol. 1996;80:203-208.  doi:10.1136/bjo.80.3.203
  39. Loskutov I. Venous thrombosis in ophthalmology. Rossiiskii meditsinskii zhurnal. 1998;16:1052-1054. (In Russ.)
  40. Bunin A, Mukha A, Davydova N. The pathogenetic factors of central retinal vein occlusion. Vestnik oftal'mologii. 1989;6:50-53. (In Russ.)
  41. Belyazo O, Saltykova N. Antiplatelet therapy in complex treatment of patients with venous thrombosis. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. 2005;4(2):33-37. (In Russ.)
  42. Tul'tseva S, Kulikov V, Shiryaev I, Yarovoy D. Branch retinal vein occlusion. Pathogenesis, visual prognosis, modern treatment methods. Oftal'mologicheskie vedomosti. 2009;2(2):30-40. (In Russ.)
  43. Volkovich T. Protective factors lacrimal liquid and their importance in the diagnosis of eye diseases. Vestnik VGMU. 2008;7(3):104-109. (In Russ.)
  44. Chesnokova N, Beznos O. Hydrolytic enzymes in normal and pathologic tear fluid. Rossiyskiy oft. zhurnal. 2012;5(4):107-111. (In Russ.)
  45. Terekhina N, Reuk S, Petrovitch Yu. Influence of viral infection on tear protein and mineral composition. Klin lab diagn. 2007;9:75. (In Russ.)
  46. Epikhin A, Kolmakova T, Khammami I. The general ideas about the chemical composition of the tear fluid and its diagnostic value. Valeologiya. 2012;4:48-50. (In Russ.)
  47. Ryzhakova O, Gureeva T, Ageev A, Moshetova L, Yarovaya G, Alekseev I, Vorob'eva I, Solov'eva N. Some biochemical indexes in burn eye injuries. Meditsinskiy alfavit. 2012;3(18):38-43. (In Russ.)
  48. Grus FH, Joachim SC, Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin. Appl. 2007;1(8):876-888.  doi:10.1002/prca.200700105
  49. Ecker SM, Hines JC, Pfahler SM, Glaser BM. Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous. Mol Vis. 2011;17:2856-2863.
  50. Noma H, Mimura T, Tatsugawa M, Shimada K. Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series. BMC Ophthalmology. 2013;13(1):78.  doi:10.1186/1471-2415-13-78
  51. Moshetova L, Yatsenko O, Yarovaya G, Neshkova E. The role of the lacrimal fluid in the diagnosis of acute vascular diseases of the retina and optic nerve. Ross med Vesti. 2004;4:50-53. (In Russ.)
  52. Volkovich T. Protective factors lacrimal liquid and their importance in the diagnosis of eye diseases. Vestnik VGMU. 2008;7(3):104-109. (In Russ.)
  53. Moshetova L, Volkov O. The modern idea of the tear fluid, its significance in the diagnosis. Klinicheskaya oftal'mologiya. 2004;5(4):138-139. (In Russ.)
  54. Somov E, Brzheskiy V. Coagulation and fibrinolytic activity of tear fluid in healthy people and in acute circulatory disorders of the eye. Vestnik oftal'mologii. 1992;3:38-41. (In Russ.)
  55. Neroev V, Chesnokova N, Tankovsky V, Pavlenko T, Grigoryev A, Urakova N. Changes of the levels of fibrinolytic system components in the blood and tears of patients during the treatment of inflammatory retinal vein occlusions. Ross oft zhurnal. 2014;7(3):27-30. (In Russ.)
  56. Mukha A, Markova O. On clinical significance of determination of some hemostatic parameters in the tear fluid of patients with vascular diseases of the retina. Vestnik oftal'mologii. 1994;(1):19-20. (In Russ.)

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.